IRIS
BUTTARI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 342
EU - Europa 339
NA - Nord America 322
SA - Sud America 2
Totale 1.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 302
SG - Singapore 212
DE - Germania 183
HK - Hong Kong 118
IT - Italia 90
CA - Canada 18
EE - Estonia 15
FI - Finlandia 11
GB - Regno Unito 11
BE - Belgio 7
NL - Olanda 6
RU - Federazione Russa 6
BD - Bangladesh 4
IL - Israele 3
LT - Lituania 3
AT - Austria 2
BR - Brasile 2
ES - Italia 2
MX - Messico 2
PK - Pakistan 2
CH - Svizzera 1
IN - India 1
IR - Iran 1
PL - Polonia 1
SE - Svezia 1
TR - Turchia 1
Totale 1.005
Salva come PNG Salva come JPEG
Città #
Hong Kong 118
Singapore 103
Falkenstein 102
Frankfurt am Main 71
West Jordan 62
Rome 55
Chicago 52
Boardman 35
Helsinki 11
Toronto 9
Ashburn 8
Brussels 7
Los Angeles 7
Buffalo 6
Moscow 6
Ottawa 6
The Dalles 6
London 5
Naples 5
San Francisco 5
Bologna 4
Charlotte 4
Sant'Elpidio a Mare 4
Santa Clara 4
Ettlingen 3
Galbiate 3
New York 3
Amsterdam 2
Elk Grove Village 2
Mexico City 2
Montreal 2
Seattle 2
São Paulo 2
Turin 2
Zona Industriale 2
Arosio 1
Atlanta 1
Boston 1
Brooklyn 1
Chennai 1
Council Bluffs 1
Dallas 1
Grellingen 1
Kiryat Ono 1
Phoenix 1
Secaucus 1
Stockholm 1
Warsaw 1
Totale 733
Salva come PNG Salva come JPEG
Nome #
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 39
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 30
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 29
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 28
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 26
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 26
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 25
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 25
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 25
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 25
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 25
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 25
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 24
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 24
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 24
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 24
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 24
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 23
Osteopontin Is Associated with Multiple Sclerosis Relapses 23
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 23
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 23
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 22
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 22
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 22
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 22
Obesity worsens central inflammation and disability in multiple sclerosis 22
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 21
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 21
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 21
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 19
Synaptic plasticity shapes brain connectivity: Implications for network topology 19
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 19
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 18
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 18
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 18
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 18
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 18
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 18
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 18
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 17
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 17
miR-142-3p Is a Key Regulator of IL-1??-Dependent Synaptopathy in Neuroinflammation 17
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 16
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 16
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 16
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 16
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 15
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 15
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 15
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 14
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 13
Totale 1.083
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024198 0 0 0 0 0 0 45 0 0 125 15 13
2024/2025885 35 45 7 49 81 57 187 186 52 35 138 13
Totale 1.083